9th Annual Biomarkers Congress

Cancer Biology: Novartis Pharmaceuticals

Total Score People Score Events Score
56 43 44
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA John Tallarico
New Approaches to Drug Discovery Chairperson: William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA Eric Martin
December 4, 2012 4th World Epigenetics Summit Epigenetics - Impact for Translational and Drug Safety Sciences Remi Terranova
May 23, 2012 Biomarkers World Europe 2012 Validation of immunoassay for protein biomarkers to support pre-clinical and clinical studies Marie-Anne Valentin
July 6, 2011 3rd WIN Symposium An example | Targeting the PI3K pathway - focused development for the treatment of cancer Samit Hirawat
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer The development of PI3K and mTOR inhibitors in cancer William R Sellers
August 25, 2010 Co-Development of Drugs and Diagnostics Lumiracoxib - Seeking a New Path Forward Through Use of a Companion Diagnostic Kevin Carl
June 1, 2010 Emerging Themes in Infection Biology Vaccines: a health insurance of the 21st century Rino Rappuoli
May 19, 2010 Towards Personalized Cancer Medicine The Discovery and Application of Cancer Therapeutics in the Genomic Era William R Sellers
PANEL DISCUSSION William R Sellers
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Biomarkers - Driven Drug and Diagnostic Co-Development in Oncology: Current Trends and Future Approaches Miro Venturi
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Challenges for Interim Data Monitoring and Decision Making in Confirmatory Adaptive Trials Paul Gallo
Evaluating Adaptive and Model-Based Approaches for Dose-Ranging Studies: An Update with Recommendations from the PhRMA Working Group Jose Pinheiro
August 26, 2009 Optimizing Mammalian Cell Lines Developing Stable Cell Lines for Protein Production Indresh K. Srivastava
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems MF59: A Safe and Potent Vaccine Adjuvant for Use in Influenza Vaccines Derek O'Hagan
Modulating the Release of Immunopotentiators to Enhance Potency of a Vaccine Formulation Using Anionic Microparticles Manmohan Singh
August 17, 2009 Fourth Annual Novel Vaccines: Design & Development Structure-Based Rational Design of HIV Env Immunogens for Vaccine Development Indresh K. Srivastava
August 5, 2009 Drug Safety Strategies to De-Risk Compounds in silico Methods in Drug Safety Josef Scheiber
June 8, 2009 RNAi for Functional Screens Development of a Flexible RNAi Screening Platform for Drug Discovery Anthony Orth
Chairperson’s Remarks Anthony Orth
June 4, 2009 Structure-Based Drug Design Main Conference Indresh K. Srivastava
June 1, 2009 Combination Products Best Practices for Performing Risk Assessment: How are small and large companies doing this? Gangadhar Sunkara
Chairperson’s Opening Remarks Gangadhar Sunkara
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Iterative Kinase Medium-Throughput Screening with 2D profile-QSAR and 3D AutoShim Models Eric Martin
February 7, 2009 Translation of the Cancer Genome SESSION 1: CHALLENGES AND OPPORTUNITIES William R Sellers
SESSION 3: HIGH-THROUGHPUT BIOLOGY: IN VITRO FUNCTIONAL GENETIC SCREEN John Tallarico
January 27, 2009 7th Annual Global Pricing and Reimbursement Congress China Jie Shen
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 1: The use of in vivo models in drug discovery imaging Thomas Krucker,
December 2, 2008 Vaccines Europe 1: Genome mining for the identification of promising antigens Mariagrazia Pizza,
1: Immunological challenges for the vaccine industry Giuseppe Del Giudice,
2 : Characterisation of vaccines by capillary electrophoresis: Applications and challenges Cristiana Campa,
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 2 : Panel Debate: How translatable is preclinical and clinical imaging? Raymond Josephsson,
2 : The importance of translatability in imaging and how this can improve preclinical and clinical trials Raymond Josephsson,
2 : Exploratory imaging in oncology clinical trials - Where are we today? Haren Rupani
December 1, 2008 European Antibody Congress 2008 Quantification of recombinant monoclonal antibodies in biological fluids for faster biotherapeutic development Francis Bitsch
October 22, 2008 HDAC Inhibitors: Targeting Oncology and Beyond Chairperson’s Remarks Peter Atadja
Development of the Pan-DAC Inhibitor Panobinostat (LBH589) in Anti-Cancer Therapy Peter Atadja
October 21, 2008 Kinase Inhibitors NVP-AEB071: Oral and Specific Inhibitor of PKC for the Prevention of Graft Rejection and the Treatment of Autoimmune Diseases Jürgen Wagner
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics The TeGenero Story: What Happened at Northwick Park and Lessons Learned Jenny Sims
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Harmonization of International Standards for Oncology Products Daniel Lapadula
Panel Discussion Daniel Lapadula
April 30, 2008 Assessment of Immunogenicity in Clinical Trials Case Study Annette Zaar
April 30, 2008 Protein Scale-Up & Manufacturing Challenges in Scaling Up the Purification Process without Compromising the Purity, Indresh K. Srivastava
March 25, 2008 PATHWAY ANALYSIS Predictive Value of in Vitro Safety Studies Willi Suter
Integrating High-Throughput Data via Pathway-Centric Analyses Joseph D Szustakowski
March 25, 2008 Clinical Trials Asia Accelerate Oncology Clinical Development in Asia Michael Shi
March 25, 2008 Preclinical Development Mechanistic Cardiac Modeling: Concepts and Utility in Drug Development Anna Georgieva
Predictive Value of in Vitro Safety Studies Willi Suter
Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 TRANSLATIONAL MEDICINE Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 CANCER MOLECULAR MARKERS Predictive Value of in Vitro Safety Studies Willi Suter
February 19, 2008 Screening Europe Track A Modern Approaches for an Old Problem: High-Throughput Screening and Compound Profiling of Proteases Lorenz Mayr
Track B Emerging GPCR Assay Technologies for Drug Discovery Sandra Siehler
December 4, 2007 7th World Drug Discovery & Development Summit 2007 Conference room 2 OPTIMISING TECHNOLOGIES TO INCREASE SPEED TO CLINIC AND SPEED TO MARKET Hans-Peter Knopf
December 1, 2007 47TH American Socieity of Cell Biology Solving Cell Culture Problems: Lori Ryan
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CONTRIBUTION OF ACADEMIC INSTITUTES (13:30-15:00) Gangadhar Sunkara
CONTRIBUTION OF ACADEMIC INSTITUTES: Pharmaceutical Research and Development Environment in India: The Contribution of Aca-demic Institutes (13:30-14:00) Gangadhar Sunkara
PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Gangadhar Sunkara
PRECLINICAL DEVELOPMENT AND CHALLENGES: INTERACTIVE PANEL :Partnership and Outsourcing Deals in India – Successes and Failures (17:00-17:45) Gangadhar Sunkara
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) CRAC – AN EMERGING TARGET (08:35-09:40) Martin Gosling
CRAC – AN EMERGING TARGET: Chairperson’s Remarks (08:35-08:40) Martin Gosling
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY: Screening Ion Channel Targets with Therapeutic Potential in Respiratory Disease: Application of Automated Electrophysiology (09:40-12:25) Martin Gosling
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY (09:40-12:25) Martin Gosling
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) Keynote Presentation (08:45-09:30) J Carl Barrett
September 27, 2007 Protein Expression Europe (Sep 27-28) Drug Discovery Applications (13:00-15:15) Lorenz Mayr
Drug Discovery Applications: Miniaturization and Automation of Protein Expression for High-Throughput Screening and Structural Biology (13:15-13:45) Lorenz Mayr
August 11, 2007 Growth factor receptor tyrosine kinases in mitogenesis, morphogenesis Targeting the mTOR kinase in human cancer Heidi A Lane
July 21, 2007 Hematopoietic Malignancies “MLL leukemia stem cells Susan Cleary
July 14, 2007 Skeletal Muscle Satellite & Stem Cells Signaling Pathways that Mediate Skeletal Muscle Atrophy & Hypertrophy David Glass
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.